CPD-002, a novel VEGFR2 inhibitor, relieves rheumatoid arthritis by reducing angiogenesis through the suppression of the VEGFR2/PI3K/AKT signaling pathway
- Resource Type
- Article
- Source
- In
International Immunopharmacology 20 April 2024 131 - Subject
- Language
- ISSN
- 1567-5769